124 related articles for article (PubMed ID: 34306405)
41. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
[TBL] [Abstract][Full Text] [Related]
42. The Efficacy of miR-20a as a Diagnostic and Prognostic Biomarker for Colorectal Cancer: A Systematic Review and Meta-Analysis.
Moody L; Dvoretskiy S; An R; Mantha S; Pan YX
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31382594
[No Abstract] [Full Text] [Related]
43. MiR-1298 expression correlates with prognosis and inhibits cell proliferation and invasion of gastric cancer.
Qiu ZK; Liu N; Zhao SF; Ding AP; Cheng G; Qiu WS; Qi WW
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1672-1679. PubMed ID: 29630111
[TBL] [Abstract][Full Text] [Related]
44. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
Li J; Zou X
Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
[TBL] [Abstract][Full Text] [Related]
45. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730
[TBL] [Abstract][Full Text] [Related]
46. Microarray expression profile of microRNAs in lung adenocarcinoma patients with the Cancer Genome Atlas and its clinical validation.
Chen G; Xing Y; Peng X; Miao L; Zhao M; Zhou H; Xiao Y
J BUON; 2020; 25(2):821-827. PubMed ID: 32521873
[TBL] [Abstract][Full Text] [Related]
47. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma.
Kim BH; Hong SW; Kim A; Choi SH; Yoon SO
J Surg Oncol; 2013 Apr; 107(5):505-10. PubMed ID: 22996433
[TBL] [Abstract][Full Text] [Related]
48. MiR-769-5p functions as an oncogene by down-regulating RYBP expression in gastric cancer.
Luan PB; Jia XZ; Yao J
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6699-6706. PubMed ID: 32633360
[TBL] [Abstract][Full Text] [Related]
49. Reduced expression of serum miR-204 predicts poor prognosis of gastric cancer.
Chen X; Liu XS; Liu HY; Lu YY; Li Y
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173244
[TBL] [Abstract][Full Text] [Related]
50. Serum
Wang G; Yang B; Wu L; Jin T; Wu Q; Zhang L; Wang L; Liu C; Liu T; Jiao S
Int J Clin Exp Pathol; 2017; 10(8):9029-9034. PubMed ID: 31966773
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis.
Zhou X; Zhu W; Li H; Wen W; Cheng W; Wang F; Wu Y; Qi L; Fan Y; Chen Y; Ding Y; Xu J; Qian J; Huang Z; Wang T; Zhu D; Shu Y; Liu P
Sci Rep; 2015 Jun; 5():11251. PubMed ID: 26059512
[TBL] [Abstract][Full Text] [Related]
52. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
[TBL] [Abstract][Full Text] [Related]
53. miR-183-5p acts as a potential prognostic biomarker in gastric cancer and regulates cell functions by modulating EEF2.
Li W; Cui X; Qi A; Yan L; Wang T; Li B
Pathol Res Pract; 2019 Nov; 215(11):152636. PubMed ID: 31558304
[TBL] [Abstract][Full Text] [Related]
54. Serum miR-126 level combined with multi- detector computed tomography in the preoperative prediction of lymph node metastasis of gastric cancer.
Feng R; Lu S; Sah BK; Beeharry MK; Zhang H; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 22(4):773-780. PubMed ID: 29843221
[TBL] [Abstract][Full Text] [Related]
55. Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance.
Zhou L; Li X; Zhou F; Jin Z; Chen D; Wang P; Zhang S; Zhuge Y; Shang Y; Zou X
Cancer Sci; 2018 Apr; 109(4):1044-1054. PubMed ID: 29450946
[TBL] [Abstract][Full Text] [Related]
56. Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer.
Yuan R; Wang G; Xu Z; Zhao H; Chen H; Han Y; Wang B; Zhou J; Hu H; Guo Z; Shen H; Xue X
Anticancer Agents Med Chem; 2016; 16(9):1093-100. PubMed ID: 26179261
[TBL] [Abstract][Full Text] [Related]
57. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
58. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
59. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
Liu W; Xu Y; Guan H; Meng H
Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
[TBL] [Abstract][Full Text] [Related]
60. Circulating SHIP2 mRNA as a novel biomarker in the diagnosis and prognosis of gastric cancer.
Xie JF; Xie NS; Tang JH; Gu QP; Luo QT
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5129-5134. PubMed ID: 29228424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
